Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.
Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.
Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels.
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
Multiple sclerosis - a dynamic field with a need for excellent education.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States.
The expression of PLP/DM-20 mRNA is restricted to the oligodendrocyte-lineage cells in the adult rat spinal cord.
Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis.
A Feasibility Study to Investigate the Effect of Functional Electrical Stimulation and Physiotherapy Exercise on the Quality of Gait of People With Multiple Sclerosis.
Vaccines and multiple sclerosis: a systematic review.
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.
Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.
Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.
Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers.
[Therapeutic development for neuromyelitis optica].
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases.
Distinct T cell signatures define subsets of patients with multiple sclerosis.
T cell chemokine receptor patterns as pathogenic signatures in autoimmunity.
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.
Antibody patterns vary arbitrarily between cerebrospinal fluid and aqueous humor of the individual multiple sclerosis patient: Specificity-independent pathological B cell function.

Pages